CN113817546A - Humic acid krill oil compound and its preparation method - Google Patents
Humic acid krill oil compound and its preparation method Download PDFInfo
- Publication number
- CN113817546A CN113817546A CN202010562508.6A CN202010562508A CN113817546A CN 113817546 A CN113817546 A CN 113817546A CN 202010562508 A CN202010562508 A CN 202010562508A CN 113817546 A CN113817546 A CN 113817546A
- Authority
- CN
- China
- Prior art keywords
- humic acid
- compound
- krill oil
- oil
- krill
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940106134 krill oil Drugs 0.000 title claims abstract description 133
- 239000004021 humic acid Substances 0.000 title claims abstract description 121
- QJZYHAIUNVAGQP-UHFFFAOYSA-N 3-nitrobicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid Chemical compound C1C2C=CC1C(C(=O)O)C2(C(O)=O)[N+]([O-])=O QJZYHAIUNVAGQP-UHFFFAOYSA-N 0.000 title claims abstract description 120
- 150000001875 compounds Chemical class 0.000 title claims abstract description 119
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000000843 powder Substances 0.000 claims abstract description 32
- 241000238557 Decapoda Species 0.000 claims abstract description 29
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 28
- 239000002904 solvent Substances 0.000 claims abstract description 23
- 239000000203 mixture Substances 0.000 claims abstract description 8
- 235000009508 confectionery Nutrition 0.000 claims description 19
- 244000269722 Thea sinensis Species 0.000 claims description 17
- 235000010208 anthocyanin Nutrition 0.000 claims description 16
- 239000004410 anthocyanin Substances 0.000 claims description 16
- 229930002877 anthocyanin Natural products 0.000 claims description 16
- 150000004636 anthocyanins Chemical class 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 16
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical group C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 claims description 14
- FCYKAQOGGFGCMD-UHFFFAOYSA-N Fulvic acid Natural products O1C2=CC(O)=C(O)C(C(O)=O)=C2C(=O)C2=C1CC(C)(O)OC2 FCYKAQOGGFGCMD-UHFFFAOYSA-N 0.000 claims description 14
- 229940095100 fulvic acid Drugs 0.000 claims description 14
- 239000002509 fulvic acid Substances 0.000 claims description 14
- 235000009569 green tea Nutrition 0.000 claims description 10
- 108010010803 Gelatin Proteins 0.000 claims description 9
- 229920000159 gelatin Polymers 0.000 claims description 9
- 239000008273 gelatin Substances 0.000 claims description 9
- 235000019322 gelatine Nutrition 0.000 claims description 9
- 235000011852 gelatine desserts Nutrition 0.000 claims description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 235000015067 sauces Nutrition 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 150000003904 phospholipids Chemical class 0.000 claims description 6
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 235000015203 fruit juice Nutrition 0.000 claims description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 5
- 241000239366 Euphausiacea Species 0.000 claims description 4
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- RASZIXQTZOARSV-BDPUVYQTSA-N astacin Chemical compound CC=1C(=O)C(=O)CC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)C(=O)CC1(C)C RASZIXQTZOARSV-BDPUVYQTSA-N 0.000 claims description 4
- 150000001746 carotenes Chemical class 0.000 claims description 4
- 235000005473 carotenes Nutrition 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 235000019165 vitamin E Nutrition 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 239000011709 vitamin E Substances 0.000 claims description 4
- 241000208140 Acer Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 102000034498 Astacin Human genes 0.000 claims description 2
- 108090000658 Astacin Proteins 0.000 claims description 2
- FMKGDHLSXFDSOU-BDPUVYQTSA-N Dienon-Astacin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(=CC1(C)C)O)C=CC=C(/C)C=CC2=C(C)C(=O)C(=CC2(C)C)O FMKGDHLSXFDSOU-BDPUVYQTSA-N 0.000 claims description 2
- 235000003676 astacin Nutrition 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 241001300674 Plukenetia volubilis Species 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 18
- 238000010521 absorption reaction Methods 0.000 abstract description 14
- 230000006870 function Effects 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 abstract 1
- 229910052698 phosphorus Inorganic materials 0.000 abstract 1
- 239000011574 phosphorus Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 22
- 235000019198 oils Nutrition 0.000 description 22
- 241000282414 Homo sapiens Species 0.000 description 16
- 239000003925 fat Substances 0.000 description 16
- 239000000126 substance Substances 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 description 12
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 10
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 10
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 10
- 235000005487 catechin Nutrition 0.000 description 10
- 150000003254 radicals Chemical class 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 8
- 210000001508 eye Anatomy 0.000 description 8
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 8
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 8
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 229950001002 cianidanol Drugs 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 235000013793 astaxanthin Nutrition 0.000 description 6
- 239000001168 astaxanthin Substances 0.000 description 6
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 6
- 229940022405 astaxanthin Drugs 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 5
- 230000003064 anti-oxidating effect Effects 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000013734 beta-carotene Nutrition 0.000 description 5
- 239000011648 beta-carotene Substances 0.000 description 5
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 5
- 229960002747 betacarotene Drugs 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 210000003491 skin Anatomy 0.000 description 5
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 5
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 238000006701 autoxidation reaction Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 230000031891 intestinal absorption Effects 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 150000001765 catechin Chemical class 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 230000006866 deterioration Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- NCYCYZXNIZJOKI-IOUUIBBYSA-N 11-cis-retinal Chemical compound O=C/C=C(\C)/C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-IOUUIBBYSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 2
- 241000758791 Juglandaceae Species 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000004330 Rhodopsin Human genes 0.000 description 2
- 108090000820 Rhodopsin Proteins 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002468 fat body Anatomy 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- -1 krill oil Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000004379 myopia Effects 0.000 description 2
- 208000001491 myopia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000004770 neurodegeneration Effects 0.000 description 2
- 208000015122 neurodegenerative disease Diseases 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960004793 sucrose Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010048908 Seasonal allergy Diseases 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048218 Xeroderma Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229940044627 gamma-interferon Drugs 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 201000000909 keratomalacia Diseases 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000005955 light diet Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000005486 organic electrolyte Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000008832 photodamage Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000003244 pro-oxidative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004436 pseudomyopia Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0092—Mixtures
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Abstract
A compound of humic acid and phosphoric shrimp oil and its preparation process, which comprises: a humic acid krill oil composition comprising: the weight ratio of each humic acid powder to the krill oil is that the content of each humic acid powder is 9-15%, the content of the krill oil is 85-91%, the humic acid powder and the krill oil are mixed to form a compound original agent, a solvent is added into the compound original agent, the weight ratio of the compound original agent to the solvent is that the content of the compound original agent is 30-50%, the content of the solvent is 50-70%, and the compound original agent and the solvent are mixed to prepare the humic acid phosphorus shrimp oil compound; therefore, the compound of the humic acid krill oil and the preparation process thereof are provided, and particularly the compound of the humic acid krill oil has the functions of promoting the absorption rate of the krill oil and reducing the rancidity rate by the aid of the auxiliary effect of humic acid and the krill oil.
Description
Technical Field
The invention provides a humic acid krill oil compound and a preparation method thereof, and particularly relates to a humic acid krill oil compound which has the functions of promoting the absorption rate of krill oil and reducing the rancidity rate by the aid of the auxiliary action of humic acid and the krill oil.
Background
Nowadays, society depends on 3C products to maintain living standards, and with the change of science and technology, science and technology dependence of people is serious, 3C products are visible everywhere in human life, 3C products are utilized to assist life, life is more convenient by science and technology, time saved by people can be contacted with more things, blue light damage generated by 3C products easily causes damage to macula lutea parts of eyes, and in order to avoid the injury of the eyeballs, 30 minutes of eyes are used for at least 10 minutes, and vision examination is performed regularly; the eye muscles are relaxed through the movement of the eyeballs, so that the phenomenon that the intraocular pressure is too high due to the tight eye muscles, the intraocular lens is pressed to form pseudomyopia is avoided, and the myopia is more easily caused for a long time; the damage of blue light to the macula is irreversible, so that various blue light resistant commodities such as polarized glasses, blue light resistant protective patches, eye protection screens and the like are sold on the market, the problem that eyeballs are affected by long-term blue light irradiation is avoided, but besides reducing the blue light irradiation, the absorption of nutrients beneficial to the eyeballs through diet is a method which most people are willing to try, and the method from common health foods such as cod liver oil, lutein, krill oil, astaxanthin and the like on the market to the improvement of dietary habits is a mainstream eye protection means at present, wherein the krill oil simultaneously contains the astaxanthin and unsaturated fatty acid, and the problems of eye protection and cardiovascular disease reduction can be simultaneously solved, so the krill oil is favored by many people.
As described above, although krill oil contains precious nutrients, the ratio of krill oil absorbed into the human body through the intestinal tract is limited, and therefore, most of the commercially available krill oil is packaged in a capsule manner to reduce the influence of gastric acid on the krill oil, so that the krill oil can smoothly reach the intestinal tract, but the absorption efficiency of the intestinal tract directly affects the efficacy of the krill oil, so that even if the edible krill oil does not necessarily have the efficacy, the unsaturated fatty acid is easily rancid, and the storage of the krill oil is not easy, which is a bottleneck problem, and improvement is urgently needed.
In view of the above, the present inventors have intensively observed and studied the related experiences in this field for many years, and applied with the help of the theory, and have intensively studied the problems of the existing humic acid krill oil compound and the process thereof, and have actively sought to solve the problems, and have succeeded in developing a humic acid krill oil compound and the process thereof through long-term research and development, and further have proposed a reasonable and effective invention to meet the needs of users.
Disclosure of Invention
The main purposes of the invention are as follows: provides a humic acid krill oil compound and a preparation process thereof, in particular to a humic acid krill oil compound which has the functions of promoting the absorption rate of krill oil and reducing the rancidity rate by the auxiliary action of humic acid and the krill oil.
In order to achieve the purpose, the invention provides a humic acid phosphate shrimp sauce compound and a preparation process thereof, which are characterized in that: comprises the following steps:
a humic acid krill oil composition comprising: the method comprises the steps of mixing a plurality of humic acid powders and krill oil in a preset proportion, wherein the weight ratio of each humic acid powder to the krill oil is that the content of each humic acid powder is 9-15% and the content of the krill oil is 85-91%, mixing the humic acid powder with the krill oil to form a compound original agent, adding a solvent into the compound original agent, and mixing the compound original agent with the solvent to prepare the humic acid phosphate shrimp oil compound, wherein the weight ratio of the compound original agent to the solvent is that the content of the compound original agent is 30-50% and the content of the solvent is 50-70%.
The invention has the following effects: by providing the humic acid krill oil compound, the rancidity of the krill oil can be effectively slowed down by virtue of the antioxidation effect of the humic acid, the intestinal absorption can be promoted by virtue of the humic acid, the absorption efficiency of the krill oil is greatly improved, the quantity of beneficial bacteria in the intestinal tract can be effectively improved by virtue of the humic acid, the intestinal absorption efficiency is further promoted to be better, phospholipid contained in the krill oil has the function of a natural emulsifier, and a compound original agent prepared by mixing the humic acid powder and the krill oil can have fat solubility and water solubility at the same time, so that the extensibility of the humic acid krill oil compound in the formula is increased, and the fat solubility and the water solubility can be mixed in the formula of the humic acid krill oil compound; therefore, the compound of the humic acid krill oil and the preparation process thereof are provided, and particularly the compound of the humic acid krill oil has the functions of promoting the absorption rate of the krill oil and reducing the rancidity rate by the aid of the auxiliary effect of humic acid and the krill oil.
Drawings
FIG. 1 is an enlarged cross-sectional view of the preferred embodiment of the present invention.
FIG. 2 is an enlarged cross-sectional view of the preferred embodiment of the present invention.
Fig. 3 is a perspective view of the preferred embodiment of the present invention.
Detailed Description
Referring to fig. 3, a compound of humic acid and shrimp sauce and its preparation method, the compound comprises: a plurality of humic acid powder 1, krill oil 2 and a solvent 3;
a krill humic acid oil compound B comprising: the method comprises the following steps of mixing a plurality of humic acid powders 1 and krill oil 2 in a preset proportion, wherein the weight ratio of each humic acid powder 1 to the krill oil 2 is that the content of each humic acid powder 1 is 9-15%, the content of the krill oil 2 is 85-91%, mixing the humic acid powder 1 with the krill oil 2 to form a compound original agent A, adding a solvent 3 into the compound original agent A, and mixing the compound original agent A with the solvent 3 to prepare the humic acid krill oil compound B, wherein the weight ratio of the compound original agent A to the solvent 3 is that the content of the compound original agent A is 30-50%, and the content of the solvent 3 is 50-70%.
With the above, the following is further described:
the humic acid powder 1 is selected from fulvic acid, the fulvic acid is a water-soluble substance refined from the humic acid again, the fulvic acid has an antioxidation effect, the krill oil 2 can be effectively assisted to be difficult to oxidize and rancid, the possibility of deterioration of the krill oil 2 is further reduced, the humic acid is weakly acidic and is attached with various trace elements, strains in intestinal tracts and the intestinal tract environment can be effectively adjusted, the absorption capacity of the intestinal tracts is further enhanced, and the absorption rate of the krill oil 2 is increased;
fulvic acid, an extremely complex black organic substance with bioactive properties, is the ultimate aerobic decomposition product of all living substances, has unusual properties and abilities to change and transform molecular combinations, contains almost all organic and inorganic substances in nature, and has the characteristics of fusion molecules, and the fulvic acid deposition is from the decomposition of a large number of vegetations by microorganisms, is a naturally occurring organic substance, is completely from rotten ancient animals and plants, and is the best known electrolyte for human beings at present: the electrolyte is a substance which is easily soluble in water or other suitable energizable media, the strength of which is clearly revealed in many animal cell tests, and its reproducibility, which is called "beauty demonstration" and "perfect experiment" by scientists, is reactivated by many times when the energy of the electrolyte is removed, which leads to cell rupture and death, e.g. electron energy is reintroduced after cell reconstruction, and studies have confirmed that similar results also occur in the human body, e.g. internal bleeding, negative emotions, loss of control, unbalanced diet, insomnia … …, which are all manifestations of potential weakness, when human death is zero, these studies confirm that proper electron uptake is of great help to human physical health, fulvic acid has been proven to be a powerful organic electrolyte, which balances cell life, and plays an important role in living cell metabolism, it assists and catalyzes the reaction of human enzyme, the hormone structure and the vitamin utilization ratio, the research finds that fulvic acid has important function to the living cell metabolism, it makes the dissolved mineral compound, element and cell biology mutually catalyze and transmute, at the same time, it causes the electron gene transfer of new mineral, it is the best known antioxidant and free radical scavenger, it has uniqueness, it can simultaneously react with negative and positive electrons, it becomes harmless free radical, it can help produce usable compound, also can remove harmful substance, also can remove heavy metal, detoxify pollutant, help to correct cell unbalance, it can help balance and promote the biological carrier contacting with it, promote biological property, it is also free radical scavenger and antioxidant, as chelate for extracting and transporting organic mineral substance and other cell nutrient substance, it possesses the ability to make bad free radicals better, according to the chemical composition of different free radicals, they can be taken in and become part of nutrients, and can provide nutrients for organism, if the chemical composition of free radical is bad, it can be chelated and assimilated, and can be removed from body, fulvic acid can stimulate thymus to produce, raise the capability of lymphocyte, and can be closely involved in antibody immune reaction in body, and can start and increase the production of macrophage and killer T cell of body, and the macrophage can consume external invader, and the killer T cell can find out and destroy them, human research shows that fulvic acid can stimulate granulocyte, and can produce cell factor including gamma-interferon, alpha-interferon, beta-interferon and tumor necrosis factor-alpha, and can control a weak balance, and the fulvic acid has strong regulation function for human physiological function, however, the effect is different from person to person and different after taking. So far, the conditioning effect takes effect quickly as shown in the following: gastrointestinal diseases, anorexia, respiratory diseases, insomnia, postoperative recovery, constipation, diarrhea, hangover relieving, late malignant tumor relieving pain, and antifatigue; in addition, the health-care wine has certain effects on physiological functions of men and women, blood sugar reduction, lymphopathy, late recovery of cerebral thrombosis and the like;
the prasudactylic acid krill oil compound B is added with the prasudactylic acid krill oil, and phospholipids contained in the krill oil 2 are used as natural emulsifiers, so that the prasudactylic acid krill oil is uniformly mixed into the prasudactylic acid krill oil compound B, wherein the Omega-3 and the fiber content are respectively 3 times and 2 times of that of walnuts, so that the operation of a cardiovascular circulation system can be enhanced, blood sugar is controlled, the probability of heart diseases is reduced, multiple supplementation can also protect eyesight and prevent macular lesions, and in addition, researches published in neurological archives also indicate that essential fatty acid in the prasudactylic acid can protect central nerves of people and prevent neurodegenerative diseases;
the compound B of the prawns humic acid is further coated with a rubber shell, the rubber shell 4 is made of edible gelatin, and the soft rubber shell coating can isolate air from oxidation and protect the krill oil 2 from being damaged easily when going through gastric acid;
the humic acid krill oil compound B is added with anthocyanin which is a natural antioxidant and can effectively inhibit the rancidity of the krill oil 2, the anthocyanin is called as oral skin cosmetics in Europe and can prevent the early generation of skin wrinkles, and the compound B can not only prevent the early generation of the skin wrinkles, but also supplement nutrition and eliminate harmful free radicals in vivo; anthocyanins are natural sun-shading materials and can prevent ultraviolet rays from invading the skin. In experiments it was found that the sun can kill 50% of human skin cells, but if protected with anthocyanins, approximately 85% of skin cells can survive death; the anthocyanin also has the effect of radiation resistance, the color of the anthocyanin changes due to different PH values, most of the anthocyanin has good light, heat and PH value stability, and the effect of the anthocyanin can be indispensable for papermen or people who are in the environment of sunshine and electric radiation for a long time; the medical clinical report shows that the anthocyanin in the blueberries can promote the regeneration of rhodopsin in retinal cells, prevent severe myopia and retinal detachment and improve the vision; the anthocyanin has strong antioxidation and antiallergic functions, can pass through a blood brain barrier, can protect cranial nerves from being oxidized, can stabilize the function of brain tissues and protect the brain from being damaged by harmful chemical substances and toxins; relieving pollinosis and other anaphylaxis, regulating humoral immunity, and improving allergic constitution; anthocyanins can improve blood circulation, recover lost microvascular efficacy, strengthen fragile blood vessels;
vitamin E oil which is a fat-soluble antioxidant is added into the humic acid krill oil compound B and can be dissolved in the krill oil 2, and the vitamin E oil is emulsified and mixed by phospholipid to form an emulsified compound solution after the vitamin E oil and the humic acid krill oil compound B are mixed;
the compound B of the humic acid krill oil is further heated and mixed with edible gelatin to prepare a compound soft sweet C of the humic acid krill oil, the compound B of the humic acid krill oil is used for heating and mixing the gelatin, the edible gelatin is dissolved and mixed with the compound B of the humic acid krill oil, and the mixture is injected into a mould and then cooled to obtain the compound soft sweet C of the humic acid krill oil;
the humic acid shrimp sauce compound soft sweets C can be adjusted in color by adding any one of anthocyanin, astaxanthin, carotene and green tea powder, so that the humic acid shrimp sauce compound soft sweets C can be more colorful and simultaneously increase the nutritional value, wherein the effect of the anthocyanin is described in the specification, and is not repeated;
astaxanthin is a common food ingredient, is a carotenoid of xanthophylls, is sometimes called astaxanthin, is naturally present in microalgae and marine animals, is orange in color, is mainly added to animal feed at an early stage, but is slowly developed into supplements for human consumption after being discovered to have special physiological activity later, has a wide research range on astaxanthin and health, and has antioxidant, anti-lipid peroxidation, skin health, liver health, anti-inflammation, anti-diabetes, cardiovascular disease prevention, anticancer activity, immunoregulation and exercise performance improvement;
carotene can improve the activity of red blood cells. The peroxidized free radicals can accelerate the aging of human bodies, people are vividly called as 'garbage' of the bodies, the beta-carotene can neutralize the peroxidized free radicals in the bodies, so the action of delaying the aging is realized, and a proper amount of the beta-carotene can promote rhodopsin to reach the normal content, thereby the slow adaptation of dark fields caused by the lack of vitamin A is avoided, and the damage of bright light to eyes after the dark fields is also avoided. In addition, night blindness, dry eye, corneal ulceration and keratomalacia can be prevented, vitamin a being necessary for maintaining the integrity of all epithelial tissues, while beta-carotene can be converted to vitamin a in the human body. Therefore, the intake of a certain amount of beta-carotene has important significance for maintaining normal body surface, digestive tract, respiratory tract, genitourinary tract and endocrine tract commodities, and can avoid skin diseases such as skin scurf, keratinization, hard and scaly epidermal cells, polyhedrosis xeroderma and the like. Beta-carotene also has a good effect on the stability of cell membranes. Can also be used for treating inflammation caused by sunlight exposure, such as "heliolitis";
the green tea powder has a plurality of tea polyphenols, wherein the tea polyphenols have more representative catechins, and researches on antioxidation at home and abroad show that the tea polyphenols, namely the TeaPolyphenols have the most representative effects of prolonging life, preserving health, resisting aging and reducing fat. The antioxidant effect of green tea is certainly accepted from the outside, but due to the improvement of biotechnology, the catechin contained in the green tea is recently found to be more finely separated into 134 types, the green tea belongs to unfermented tea, the catechin content of the green tea is the highest in various tea types, generally the total catechin content accounts for 10% -30% of the dried green tea, if the green tea powder after low-temperature grinding is washed by water and dissolved, 40% -50% of the total catechin can be released, the total catechin is also the most main flavor source of tea soup, the catechin in the tea mainly comprises free EC (epicatechin), EGC (epigallocatechin) and esterified ECG (epicatechin-3-gap) and EGCG (epigallotechin-3-gap), wherein the EGCG content is the highest and the highest in bioactivity, in other words, the catechin is not effective, in a precise comparison, it should be noted that the source of total catechins and the composition of catechins, EGCG in high concentration can resist oxidation, prevent chronic cardiovascular disease, resist cancer, significantly improve the ability to scavenge free radicals, and further chelate metal ions to reduce oxidation, reduce lipid oxidation, inhibit blood glucose rise, eliminate odor, and resist inflammation. In addition, the EGCG can obviously and effectively eliminate stubborn fat in a human body, has 8 oh bonds and has the capacity of strongly absorbing and removing free radicals, when positive electricity on the surface of long-chain large fat (stubborn fat stored for a long time) is met by the EGCG with the 8 oh bonds, the EGCG is easy to be chelated and self-disintegrated into small fat, the small fat is contacted with the EGCG again and then disintegrated and separated to form unsaturated fatty acid, and the unsaturated fatty acid is beneficial to the human body, harmless, easy to use by the human body, easy and smooth to enter a metabolic circulation system and can be combusted or discharged out of the body. The oh bond of EGCG can not only disassemble the long-accumulated stubborn fat, but also has the capability of preventing the unsaturated fatty acid from being reduced into fat by reverse action, can wrap the small fat body and the unsaturated fatty acid and prevent the small fat body and the unsaturated fatty acid from being combined to form fat, and based on the same theory, EGCG can solve the phenomenon of overhigh blood fat or excessively thick blood quality in the blood vessel, prevent cardiovascular diseases, such as reducing the risk of myocardial infarction, reducing calcification of the artery wall, accumulation of sediments in the blood vessel, preventing atherosclerosis, delaying the gasification of low-density fat LDL (if the fatty acid in LDL is oxidized, macrophage in the blood vessel epithelial cell can be promoted to form foam cell, atherosclerosis lesion is caused), Can obviously reduce the concentration of cholesterol and triglyceride in blood and increase the discharge amount and efficiency of the cholesterol and triglyceride from the body. People who have less exercise or like eating big fish and big meat and do not like light diet can balance the deficiency of the health elements in the body by using the intake of EGCG;
the compound soft sweets C containing the humic acid phosphate shrimp oil are added with any one of maple sugar, honey and cane sugar, and are used for improving the flavor of the compound soft sweets C containing the humic acid phosphate shrimp oil;
the compound soft sweets C containing the prawns oil humates are added with concentrated fruit juice, and the fragrance of the natural concentrated fruit juice is utilized to make the compound soft sweets C containing the prawns oil humates have more flavor;
with the above contents, the explanation of the usage of the compound humic acid-containing krill oil and the preferred embodiment of the preparation process thereof of the present invention includes: a plurality of humic acid powder 1, krill oil 2 and a solvent 3; wherein: the respective formulations of humic acid powder 1, krill oil 2, and solvent 3 are described above, and therefore, the following are not described:
average results of the krill oil 2 random control test
| LDL-C | TG | HDL-C |
| -15.52mg/dL | -14.03mg/dL | +6.65mg/dL |
The average result of the humic acid krill oil compound B random control test
| LDL-C | TG | HDL-C |
| -18.71mg/dL | -16.58mg/dL | +7.12mg/dL |
The humic acid and shrimp oil compound soft sweets C has average result of random control test
As is apparent from the above table, humic acid has significant improvement on the improvement of the krill oil 2 for reducing cholesterol and triglyceride, and the subjects in the above table ingest the same amount of the krill oil 2 for two weeks, ingest 500 mg of the krill oil 2 per day, and the result is obviously improved by the compound added with humic acid;
particularly, the test result of the prawns oil humate compound soft sweets C can show that the effect is also improved, although the test result is slightly reduced by adding gelatin and sugar into the compound, the data can be obviously improved on the whole, and thus, the humic acid has an obvious effect of increasing the absorption of the krill oil 2;
the krill oil 2 rancidity test was as follows:
| |
Compound original agent A | Humic acid krill oil compound B | |
| First day | 0.1％ | 0.1％ | 0.1％ |
| The second day | 5.3％ | 0.9％ | 1.2％ |
| The third day | 11.7％ | 2％ | 2.3％ |
| The fourth day | 19.2％ | 2.8％ | 3.1％ |
| The fifth day | 28.7％ | 4.3％ | 5.6％ |
| The sixth day | 32.9％ | 6.9％ | 8.3％ |
| The seventh day | 38.5％ | 8.2％ | 9.8％ |
Unit: the POV content percentage is placed in a glass culture dish in an upper table test mode and is tested in a mode of contacting with air at a long temperature, and the test result shows that humic acid can effectively reduce the rancidity speed of the krill oil 2, so that the storage time of the krill oil 2 is prolonged, and deterioration is avoided;
autoxidation (autoxidation) of fats is a major cause of food spoilage. The autoxidation is that unsaturated fatty acid reacts with oxygen under the catalysis of radiation, pro-oxidant or enzyme, the oxidation occurs at the position of double bond on the carbon chain of fatty acid to generate hydroperoxide, and then the hydroperoxide is decomposed into polar volatile or non-volatile lysate of aldehyde, ketone and acid, thereby generating pungent odor. The peroxide value is a detection method for measuring the content of hydroperoxide in oil products;
the peroxide value (POV) is determined according to the autoxidation of the grease. During the oil frying process, because of high temperature and long-time contact with air, the rising of the POV is inevitable, but if the food has acid or alkali to catalyze the peroxide, the POV of the oil can rise rapidly;
also, a krill humic acid compound B, comprising: the preparation method comprises the following steps of mixing a plurality of humic acid powders 1 and krill oil 2 in a preset proportion, wherein the weight ratio of each humic acid powder 1 to the krill oil 2 is that the content of each humic acid powder 1 is 9-15%, the content of the krill oil 2 is 85-91%, mixing the humic acid powder 1 with the krill oil 2 to form a compound original agent A, adding a solvent 3 into the compound original agent A, and mixing the compound original agent A with the solvent 3 to prepare a humic acid krill oil compound B, wherein the weight ratio of the compound original agent A to the solvent 3 is that the content of the compound original agent A is 30-50%, and the content of the solvent 3 is 50-70%;
the compound B of the prawns oil humate can be directly used as oral liquid, or edible gelatin is mixed to prepare the compound soft sweets C of the prawns oil humate, or the compound B of the prawns oil humate can be further coated with a rubber shell 4, the rubber shell 4 is made of the edible gelatin, the soft rubber shell coating can isolate air from oxidation, and protect the krill oil 2 from being damaged easily when the krill oil passes through gastric acid, so that the compound B of the prawns oil humate can be eaten conveniently;
the humic acid powder 1 is selected from fulvic acid, the fulvic acid is a water-soluble substance refined from the humic acid again, the fulvic acid has an antioxidation effect, the krill oil 2 can be effectively assisted to be difficult to oxidize and rancid, the possibility of deterioration of the krill oil 2 is further reduced, the humic acid is weakly acidic and rich in various trace elements, strains in intestinal tracts and the intestinal tract environment can be effectively adjusted, the absorption capacity of the intestinal tracts is further enhanced, and the absorption rate of the krill oil 2 is increased;
the prasudactylic acid krill oil compound B is added with the prasudactylic acid krill oil, and phospholipids contained in the krill oil 2 are used as natural emulsifiers, so that the prasudactylic acid krill oil is uniformly mixed into the prasudactylic acid krill oil compound B, wherein the Omega-3 and the fiber content are respectively 3 times and 2 times of that of walnuts, so that the operation of a cardiovascular circulation system can be enhanced, blood sugar is controlled, the probability of heart diseases is reduced, multiple supplementation can also protect eyesight and prevent macular lesions, and in addition, researches published in neurological archives also indicate that essential fatty acid in the prasudactylic acid can protect central nerves of people and prevent neurodegenerative diseases;
the compound shrimp sauce C containing humic acid is added with any one of anthocyanin, astacin, carotene and green tea powder, so that the compound shrimp sauce C containing humic acid can be adjusted in color by adding the components, and the compound shrimp sauce C containing humic acid can be more bright in color and simultaneously increase the nutritional value;
the compound soft sweets C containing the humic acid phosphate shrimp oil are added with any one of maple sugar, honey and cane sugar, and are used for improving the flavor of the compound soft sweets C containing the humic acid phosphate shrimp oil;
the compound soft sweets C containing the prawns oil humates are added with concentrated fruit juice, and the fragrance of the natural concentrated fruit juice is utilized to make the compound soft sweets C containing the prawns oil humates have more flavor;
finally, the main objective of the invention is to: by providing the humic acid krill oil compound, the rancidity of the krill oil 2 can be effectively slowed down by the oxidation resistance of humic acid, intestinal absorption can be promoted by the humic acid, the absorption efficiency of the krill oil 2 is greatly improved, the quantity of beneficial bacteria in the intestinal tract can be effectively improved by the humic acid, the intestinal absorption efficiency is further improved, phospholipid contained in the krill oil 2 has the function of a natural emulsifier, and a compound original agent A prepared by mixing the humic acid powder 1 and the krill oil 2 can have fat solubility and water solubility at the same time, so that the extensibility of the humic acid krill oil compound B in the formula is increased, and the fat solubility and the water solubility of the humic acid krill oil compound B can be mixed in the formula at the same time; therefore, the compound of the humic acid krill oil and the preparation process thereof are provided, and particularly the compound of the humic acid krill oil has the functions of promoting the absorption rate of the krill oil and reducing the rancidity rate by the aid of the auxiliary effect of humic acid and the krill oil.
From the foregoing, it is understood that the present invention is capable of being widely applied to various industries, and has advantages of advancement and novelty. However, the above description is only a preferred embodiment of the present invention, and the scope of the present invention should not be limited by the above description; therefore, all the equivalent changes and modifications made according to the claims of the present invention should be covered by the scope of the present invention.
Claims (10)
1. A humic acid-containing shrimp sauce compound and a preparation process thereof, which is characterized in that: comprises the following steps:
a humic acid krill oil composition comprising: the method comprises the steps of mixing a plurality of humic acid powders and krill oil in a preset proportion, wherein the weight ratio of each humic acid powder to the krill oil is that the content of each humic acid powder is 9-15% and the content of the krill oil is 85-91%, mixing the humic acid powder with the krill oil to form a compound original agent, adding a solvent into the compound original agent, and mixing the compound original agent with the solvent to prepare the humic acid phosphate shrimp oil compound, wherein the weight ratio of the compound original agent to the solvent is that the content of the compound original agent is 30-50% and the content of the solvent is 50-70%.
2. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: wherein the humic acid powder is selected from fulvic acid.
3. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: the compound of the humic acid krill oil is added with the Plukenetia volubilis oil, and phospholipids contained in the krill oil are used as natural emulsifiers, so that the Plukenetia volubilis oil is uniformly mixed into the compound of the humic acid krill oil.
4. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: wherein the compound humic acid krill oil is further coated with a rubber shell, and the rubber shell is made of edible gelatin.
5. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: wherein the humic acid-containing krill oil compound is further added with anthocyanin.
6. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: wherein the humic acid krill oil compound is further added with vitamin E oil.
7. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: the compound krill humic acid oil soft sweets are prepared by heating and mixing the compound krill humic acid oil with edible gelatin.
8. The humic acid-containing krill oil compound and the preparation method thereof as claimed in claim 7, wherein: wherein the humic acid and shrimp oil compound soft sweet is added with any one of anthocyanin, astacin, carotene and green tea powder.
9. The humic acid-containing krill oil compound and the preparation method thereof as claimed in claim 7, wherein: wherein the humic acid-containing krill oil compound soft candy is added with one of maple sugar, honey and sucrose.
10. The humic acid-containing krill oil compound and the preparation process thereof as claimed in claim 1, wherein: wherein the compound soft sweet of the humic acid phosphoric shrimp oil is added with concentrated fruit juice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010562508.6A CN113817546A (en) | 2020-06-18 | 2020-06-18 | Humic acid krill oil compound and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010562508.6A CN113817546A (en) | 2020-06-18 | 2020-06-18 | Humic acid krill oil compound and its preparation method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113817546A true CN113817546A (en) | 2021-12-21 |
Family
ID=78924540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010562508.6A Pending CN113817546A (en) | 2020-06-18 | 2020-06-18 | Humic acid krill oil compound and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113817546A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120213756A1 (en) * | 2011-02-21 | 2012-08-23 | Rosemary Petralia | Nutraceutical beverage |
| CN104546910A (en) * | 2014-12-18 | 2015-04-29 | 昆明理工大学 | Application of fulvic acid in preparing appetite improving and digestion promoting oral preparation |
| CN104643100A (en) * | 2015-02-11 | 2015-05-27 | 浙江康恩贝集团医疗保健品有限公司 | Health food with anti-oxidization function |
| CN104824651A (en) * | 2015-05-25 | 2015-08-12 | 武汉志邦化学技术有限公司 | High-content krill oil microcapsules and preparation technology thereof |
| CN105146543A (en) * | 2015-07-14 | 2015-12-16 | 威海御膳坊生物科技有限公司 | Krill oil compound preparation for improving immunity and treating three highs |
-
2020
- 2020-06-18 CN CN202010562508.6A patent/CN113817546A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120213756A1 (en) * | 2011-02-21 | 2012-08-23 | Rosemary Petralia | Nutraceutical beverage |
| CN104546910A (en) * | 2014-12-18 | 2015-04-29 | 昆明理工大学 | Application of fulvic acid in preparing appetite improving and digestion promoting oral preparation |
| CN104643100A (en) * | 2015-02-11 | 2015-05-27 | 浙江康恩贝集团医疗保健品有限公司 | Health food with anti-oxidization function |
| CN104824651A (en) * | 2015-05-25 | 2015-08-12 | 武汉志邦化学技术有限公司 | High-content krill oil microcapsules and preparation technology thereof |
| CN105146543A (en) * | 2015-07-14 | 2015-12-16 | 威海御膳坊生物科技有限公司 | Krill oil compound preparation for improving immunity and treating three highs |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652867B (en) | A kind of health-care flax powder and production method thereof | |
| CN105613789B (en) | High-fat high-dietary-fiber composite animal and plant powdered oil and fat, and preparation method and application thereof | |
| CA2715261C (en) | Food products containing omega-3 fatty acids | |
| KR102409377B1 (en) | Composition for improving dry eyes and preventing tear pigmentation for pets | |
| CN102204595B (en) | Functional edible oil containing lycoypene | |
| CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
| CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
| CN108782874A (en) | A kind of selenium-rich black tea drinks | |
| TW202116174A (en) | Composite edible oil and preparation method thereof | |
| JP2023549130A (en) | Composition comprising 5-aminolevulinic acid hydrochloride | |
| CN106173194A (en) | A kind of biological antioxidant of animal feed | |
| CN113855735B (en) | Composition for promoting metabolic digestion and preparation method thereof | |
| CN106614905B (en) | Preparation method of nutritional rice cake for infants | |
| CN113817546A (en) | Humic acid krill oil compound and its preparation method | |
| Hans et al. | Algal-derived physiologically active nutraceuticals: Dietary supplements, vitamins, carotenoids, fatty acids and other novel products | |
| KR102131341B1 (en) | The manufacturing method of functional sunsik | |
| CN115024493A (en) | Active ingredient loaded nutrition microsphere and preparation method and application thereof | |
| CN108703373A (en) | A kind of seven color nutrients | |
| TW202200166A (en) | Humic acid krill oil compound and its process | |
| Selvaraj et al. | Virgin coconut oil: A nutraceutical and therapeutic food | |
| KR20200046957A (en) | Health functional food composition comprising organic cale as main component | |
| AU2021101163A4 (en) | An algal oil DHA drop agent and its preparation method | |
| RU2778561C1 (en) | Method for obtaining a biologically active additive | |
| CN1079649C (en) | Nutrient concurrently used as medicated diet and cosmetics for preventing and curing hypersensitive stain, senility and obesity and its manufacture method | |
| RU2385660C2 (en) | Vegetable concentrate for functional drink "kazan-bionan-2" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211221 |